Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Product revenue, net	$ 18,561	$ 2,296
Other revenue	12	85
Total revenues	18,573	2,381
Cost of product revenue	25,864	5,512
Gross margin	(7,291)	(3,131)
Operating expenses:
Selling, general and administrative	46,329	37,467
Research and development	25,072	41,587
Total operating expenses	71,401	79,054
Gain from sale of priority review voucher, net	0	92,930
(Loss) income from operations	(78,692)	10,745
Interest income	2,579	2,828
Interest expense	(4,856)	(4,270)
Other income, net	11,165	9,627
(Loss) income before income taxes	(69,804)	18,930
Income tax (expense) benefit	0	0
Net (loss) income	$ (69,804)	$ 18,930
Net (loss) income per share - basic (in dollars per share)	$ (0.36)	$ 0.18
Net (loss) income per share - diluted (in dollars per share)	$ (0.36)	$ 0.18
Weighted-average number of common shares used in computing net (loss) income per share - basic (in shares)	193,151	102,920
Weighted-average number of common shares used in computing net (loss) income per share - diluted (in shares)	193,151	103,303
Other comprehensive (loss) income:
Total other comprehensive (loss) income	$ (312)	$ 984
Comprehensive (loss) income	$ (70,116)	$ 19,914